ID   WD PaCa
AC   CVCL_8435
SY   WDPaCa; Well-Differentiated Pancreatic adenoCarcinoma; WD
DR   Wikidata; Q54993685
RX   PubMed=3971476;
RX   PubMed=6435863;
RX   PubMed=6805945;
RX   PubMed=8863680;
CC   Doubling time: ~24 hours (PubMed=3971476).
CC   Transformant: ChEBI; CHEBI_134609; Nitrosobis(2-oxopropyl)amine.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
RX   PubMed=3971476; DOI=10.1007/BF00434351;
RA   Chang B.K., Gregory J.A.;
RT   "Comparison of the cellular pharmacology of doxorubicin in resistant
RT   and sensitive models of pancreatic cancer.";
RL   Cancer Chemother. Pharmacol. 14:132-134(1985).
//
RX   PubMed=6435863;
RA   Chang B.K., Black O. Jr., Gutman R.;
RT   "Inhibition of growth of human or hamster pancreatic cancer cell lines
RT   by alpha-difluoromethylornithine alone and combined with
RT   cis-diamminedichloroplatinum(II).";
RL   Cancer Res. 44:5100-5104(1984).
//
RX   PubMed=6805945;
RA   Chang B.K., Gutman R.;
RT   "Chemotherapy of pancreatic adenocarcinoma: initial report on two
RT   transplantable models in the Syrian hamster.";
RL   Cancer Res. 42:2666-2670(1982).
//
RX   PubMed=8863680; PMCID=PMC1865186;
RA   Erill N., Cuatrecasas M., Sancho F.J., Farre A., Pour P.M., Lluis F.,
RA   Capella G.;
RT   "K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas
RT   and cell lines.";
RL   Am. J. Pathol. 149:1333-1339(1996).
//